Burney Co. Acquires 245 Shares of The Clorox Company (NYSE:CLX)

Burney Co. grew its position in shares of The Clorox Company (NYSE:CLXFree Report) by 5.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,848 shares of the company’s stock after buying an additional 245 shares during the period. Burney Co.’s holdings in Clorox were worth $635,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. lifted its position in shares of Clorox by 0.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 663,638 shares of the company’s stock valued at $86,963,000 after buying an additional 3,696 shares during the last quarter. Janney Montgomery Scott LLC lifted its position in shares of Clorox by 1.6% during the 3rd quarter. Janney Montgomery Scott LLC now owns 117,936 shares of the company’s stock valued at $15,458,000 after buying an additional 1,859 shares during the last quarter. Atria Wealth Solutions Inc. lifted its position in shares of Clorox by 13.7% during the 3rd quarter. Atria Wealth Solutions Inc. now owns 22,077 shares of the company’s stock valued at $2,893,000 after buying an additional 2,663 shares during the last quarter. Mattern Capital Management LLC lifted its holdings in Clorox by 9.2% during the 3rd quarter. Mattern Capital Management LLC now owns 44,108 shares of the company’s stock worth $5,781,000 after purchasing an additional 3,714 shares in the last quarter. Finally, First Command Advisory Services Inc. purchased a new stake in Clorox during the 3rd quarter worth about $124,000. Hedge funds and other institutional investors own 77.98% of the company’s stock.

Clorox Price Performance

Shares of Clorox stock opened at $153.20 on Friday. The firm has a market capitalization of $19.01 billion, a PE ratio of 243.18, a price-to-earnings-growth ratio of 2.34 and a beta of 0.43. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $178.21. The business’s 50-day moving average price is $144.23 and its 200-day moving average price is $141.92. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter in the previous year, the company posted $0.98 earnings per share. The business’s revenue was up 16.0% on a year-over-year basis. Sell-side analysts forecast that The Clorox Company will post 5.59 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 9th. Investors of record on Wednesday, January 24th were issued a dividend of $1.20 per share. The ex-dividend date was Tuesday, January 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.13%. Clorox’s dividend payout ratio is presently 761.92%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CLX. Bank of America raised Clorox from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $120.00 to $150.00 in a report on Friday, December 15th. Jefferies Financial Group began coverage on Clorox in a report on Monday, November 13th. They set an “underperform” rating and a $117.00 price objective on the stock. Barclays increased their price objective on Clorox from $115.00 to $118.00 and gave the stock an “underweight” rating in a report on Tuesday, January 16th. UBS Group upped their target price on Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, February 2nd. Finally, DA Davidson restated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research note on Monday, February 5th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $144.64.

Check Out Our Latest Stock Report on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.